Double procedure may keep AFib away longer

NCT ID NCT07320768

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a nerve-calming kidney procedure (renal denervation) to standard heart ablation (pulsed-field ablation) can better prevent atrial fibrillation from coming back. About 86 adults with persistent AFib will be randomly assigned to get either the combination or ablation alone. The main goal is to see if the combo keeps the heart in normal rhythm for at least 12 months without needing antiarrhythmic drugs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
renal denervation and pulsed-field ablation (both catheter-based procedures)
What this could lead to
If successful, this combination procedure could reduce the chance of atrial fibrillation coming back after ablation, potentially decreasing the need for repeat procedures or long-term medication.
What could go wrong
This is a small, early-stage trial (86 participants) and results may not apply to everyone. The procedures carry risks like bleeding, blood vessel damage, or heart rhythm issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai Chest Hospital

    Shanghai, 200030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.